Ridgetech, Inc. (RDGT) Stock Score, Valuation & Financial Research
Ridgetech, Inc. is in the Healthcare sector and Medical - Distribution industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 57/100.
Quick answer for RDGT
Ridgetech, Inc. currently has a Wall Street Score of 57/100. The stored market price is $0.83. Its financial score is 25/100. Its valuation score is 100/100. The latest WSS change is -7.8 points. These figures are a research snapshot, not a buy or sell recommendation.
What Ridgetech, Inc. does
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
RDGT financial snapshot
- Wall Street Score:
- 57/100
- Current price:
- $0.83
- Market capitalization:
- $745K
- Revenue:
- $252.1M
- Net income:
- $8.9M
- Free cash flow:
- $-1.4M
- Cash:
- $17.9M
- Total debt:
- $23K
- EPS:
- 9562266.91
- P/E ratio:
- 0.0x
- Financial score:
- 25/100
- Valuation score:
- 100/100
- Revenue score:
- 56/100
What stands out
- Reported year-over-year revenue growth is +0.9%.
- Free cash flow is $-1.4M, showing cash burn in the current stored period.
- The balance sheet shows $17.9M of cash versus $23K of total debt, leaving more cash than debt.
- The latest Wall Street Score change is -7.8 points: RDGT decreased 7.8 points because Debt declined by 89 points, Buffett declined by 19.8 points.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-13.
How to research RDGT
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.